SCHEMBL9517152

SCHEMBL9517152

CCCCOCCOc1ccc(S(=O)(=O)NC(=O)c2ccc(CO)nc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.48
MCL1 Q07820 1/20 0.48
P4HTM Q9NXG6 2/20 0.47
MMP1 P03956 2/20 0.47
ADAMTS4 O75173 1/20 0.47
MMP2 P08253 1/20 0.47
MMP13 P45452 1/20 0.47
MMP14 P50281 1/20 0.47
ADAMTS5 Q9UNA0 1/20 0.47
RARB P10826 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
EGFR P00533 2/20 0.44
LMNA P02545 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.42
GAA P10253 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515565 0.95 BCL2L1 (0.53) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9519133 0.93 BCL2L1 (0.51) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9516188 0.92 BCL2L1 (0.50) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9519606 0.92 BCL2L1 (0.50) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9516980 0.92 BCL2L1 (0.50) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9517238 0.86 P4HTM (0.55) BCL2L1MCL1P4HTMEGFR
SCHEMBL9518008 0.86 P4HTM (0.54) BCL2L1MCL1P4HTMMAPTSMN1; SMN2
SCHEMBL9517947 0.85 NPC1 (0.56) BCL2L1MCL1TP53MAPTSMN1; SMN2
SCHEMBL9516161 0.84 P4HTM (0.53) BCL2L1MCL1P4HTMMMP1ADAMTS4
SCHEMBL9518006 0.82 P4HTM (0.67) P4HTMMMP1MMP2MMP13EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed